Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure

Menopause

Volumn 12, Issue 6, 2005, Pages 749-754

  Dixit, Hridesh ^a   Rao, Lakshmi K ^a   Padmalatha, Venkata ^a   Kanakavalli, Murthy ^a   Deenadayal, Mamatha ^b   Gupta, Nalini ^c   Chakravarty, Baidyanath ^c   Singh, Lalji ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b Infertility Institute and Research Centre   (India)

^c Institute of Reproductive Medicine   (India)

Author keywords

Candidate gene; GDF9; Mutation; Ovarian failure

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 9;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENETIC SCREENING; GENOTYPE; HAPLOTYPE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PREMATURE OVARIAN FAILURE; PRIMARY AMENORRHEA; SECONDARY AMENORRHEA; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; BONE MORPHOGENETIC PROTEIN 15; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENOTYPE; GROWTH DIFFERENTIATION FACTOR 9; HAPLOTYPES; HUMANS; INDIA; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KARYOTYPING; MIDDLE AGED; MUTATION; MUTATION, MISSENSE; OVARIAN FAILURE, PREMATURE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PRIMARY OVARIAN INSUFFICIENCY;

EID: 27944490382     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gme.0000184424.96437.7a     Document Type: Article

References (22)

1. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604-606.
2. Schlessinger D, Herrera L, Crisponi L, et al. Genes and translocations involved in POF. Am J Med Genet 2002;111:328-333.
3. Achermann JC, Ozisik G, Meeks JJ, Jameson JL. Genetic causes of human reproductive disease. J Clin Endocrinol Metab 2002;87:2447-2454.
4. Aittomaki K, Lucena JLD, Pakarinen P, et al. Mutation in the follicle stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995;82:959-968.
5. Crisponi L, Deiana M, Loi A, et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus/inversus syndrome. Nat Genet 2001;27:159-166.
6. Shelling AN, Burton KA, Chand AL, et al. Inhibin: a candidate gene for premature ovarian failure. Hum Reprod 2000;15:2644-2649.
7. Marozzi A, Porta C, Vegetti W, et al. Mutation analysis of the inhibin alpha gene in a cohort of Italian women affected by ovarian failure. Hum Reprod 2002;17:1741-1745.
8. Dixit H, Deenadayal M, Singh L. Mutational analysis of the mature peptide region of inhibin genes in Indian women with ovarian failure. Hum Reprod 2004;19:1760-1764.
9. Welt CK, Hall JE, Adams JM, Taylor AE. Relationship of estradiol and inhibin to the FSH variability in hypergonadotropic hypogonadism or premature ovarian failure. J Clin Endocrinol Metab 2004;DOI:10.1210/jc.2004-1319.
10. Roh JS, Bondestam J, Mazerbourg S, et al. Growth differentiation factor-9 stimulates inhibin production and activates Smad2 in cultured rat granulosa cells. Endocrinology 2003;144:172-178.
11. Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM. Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol 1999;13:1035-1048.
12. Latham KE, Wigglesworth K, McMenamin M, Eppig JJ. Stage-dependent effects of oocytes and growth differentiation factor 9 on mouse granulosa cell development: advance programming and subsequent control of the transition from preantral secondary follicles to early antral tertiary follicles. Biol Reprod 2004;70:1253-1262.
13. Dong JW, Albertini DF, Nishimori K, Kumar TR, Lu NF, Matzuk MM. Growth differentiation factor-9 is required during early ovarian growth folliculogenesis. Nature 1996;383:531-535.
14. Takebayashi K, Takakura K, Wang HQ, Kimura F, Kasahara K, Noda Y. Mutation analysis of the growth differentiation factor-9 and -9B genes in patients with premature ovarian failure and polycystic ovary syndrome. Fertil Steril 2000;74:976-979.
15. Fitzpatrick SL, Sindoni DM, Shughrue PJ, Lane MV, Merchenthaler IJ, Frail DE. Expression of growth differentiation factor-9 messenger ribonucleic acid in ovarian and non-ovarian rodent and human tissues. Endocrinology 1998;139:2571-2578.
16. Aaltonen J, Laitinen MP, Vuojolainen K, et al. Human growth differentiation factor 9 (GDF-9) and its novel homolog GDF-9B are expressed in oocytes during early folliculogenesis. J Clin Endocrinol Metab 1999;84:2744-2750.
17. Vitt UA, Mazerbourg S, Klein C, Hsueh AJW. Bone morphogenetic protein receptor type II is a receptor for growth differentiation factor-9. Biol Reprod 2002;67:473-480.
18. Mazerbourg S, Klein C, Roh J, et al. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5. Mol Endocrinol 2004;18:653-665.
19. Liao WX, Moore RK, Otsuka F, Shimasaki S. Effect of intracellular interaction on the processing and secretion of Bone morphogenetic protein-15 (BMP-15) and growth and differentiation factor-9. J Biol Chem 2003;279:3713-3719.
20. Liao WX, Moore RK, Shimasaki S. Functional and molecular characterization of naturally occurring mutations in the oocyte-secreted factors bone morphogenetic protein-15 and growth and differentiation factor-9. J Biol Chem 2004;279:17391-17395.
21. Vitt UA, Hayashi M, Klein C, Hsueh AJW. Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol Reprod 2000;62:370-377.
22. Vitt UA, McGee EA, Hayashi M, Hsueh AJW. In vivo treatment with GDF-9 stimulates primordial and primary follicle progression and theca cell marker CYP17 in ovaries of immature rats. Endocrinology 2000;141:3814-3820.